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Summary In order to identify potential markers of prognosis in breast cancer, representative cDNA libraries
were constructed using RNA isolated from primary breast tumour tissue associated with good and poor
prognosis. Cross-screening of these libraries repeatedly identified cloned mRNA species associated with the
immune system, in particular B-cells, in libraries derived from tumours of poor prognosis. We have used one
of these, a KIV light chain cDNA probe, in two complementary studies to investigate the relationship between
immunoglobin gene expression and prognosis. The results obtained using a combination ofS, mapping, RNA
blotting and in situ hybridisation demonstrate that the presence of plasma cells, as defined by infiltrating cells
which express high levels of immunoglobulin K-chain mRNA, is associated with a poor prognosis.
A large proportion of women with operable primary breast
cancer have occult micrometastases at presentation. The
most accurate indicator of the presence of metastases is the
extent of axillary lymph node involvement assessed by a
pathologist after complete axillary dissection. However the
introduction of breast conservation has reduced axillary
dissections and the prognostic information derived from the
determination of nodal involvement. This has led to a search
for useful prognostic markers of metastases present within
the primary tumour tissue such as histological grade
(Richardson & Bloom, 1957), steroid receptor proteins
(Howell et al., 1984), milk fat globule antigens (Wilkinson et
al., 1984), neu oncogene expression (Slamon et al., 1987) and
cell surface glycoproteins (Leatham & Brooks, 1987).
However, none of these markers is sufficiently accurate for
clinical use, and new, more precise markers of prognosis
would be of great value in order to plan appropriate
treatments, and for the psychological management of the
patient and her family.
In a series of experiments designed to identify novel
markers of poor prognostic significance we constructed large
cDNA libraries in bacteriophage AgtI0 using poly(A)-
containing RNA isolated from primary breast tumour tissue
associated with good and poor prognosis. Cross-screening of
these libraries tepeatedly identified mRNA sequences
associated with the immune system, in particular B-cells, in
the cDNA library constructed from poor prognosis tumour
tissue, suggesting a potential correlation between the
presence of infiltrating cells of the immune system and poor
prognosis. Here we describe S, mapping, RNA blotting and
in situ hybridisation studies using a cloned human immuno-
globulin light K-chain cDNA hybridisation probe. These
provide evidence that the presence of plasma cells, as defined
by infiltrating cells producing high levels of immunoglobulin
K-chain mRNA, is associated with poor prognosis in primary
mammary carcinoma.
Materials and methods
Reagents
[oL-32P]dCTP (800 Ci mmol- 1) and [L-32P]CTP
(800 Ci mmol -) were obtained from New England Nuclear
(Boston, MA, USA). Restriction endonucleases and
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modifying enzymes were purchased from Boehringer
Corporation Ltd. (Lewes, UK) or Amersham International
plc (Amersham, UK). The cloning vectors pUC13, M13
mplO and M13 mpll were purchased from Pharmacia
(Uppsala, Sweden) whilst pGEM 1 and pGEM 2 were from
P & S Biochemicals (Liverpool, UK). All other materials
were from sources described elsewhere (Edbrooke et al.,
1985; Pemble et al., 1986).
Patients and pathological material
Primary breast tumour tissue for RNA extraction was
obtained from patients involved in clinical trials at The
Christie Hospital and Holt Radium Institute, Manchester.
For retrospective studies, formalin fixed, paraffin embedded
breast carcinoma tissue was obtained from the Department
of Pathology, Norfolk & Norwich General Hospital,
Norwich. Tissue for RNA extraction was frozen in liquid
nitrogen immediately after excision. For in situ hybridisation
studies formalin fixed tissues were processed and embedded
in paraffin wax in routine pathology laboratories, without
special precautions to prevent RNA degradation, then stored
at ambient temperature for up to 11 years.
RNA isolation
Total RNA was extracted from frozen tumour tissue essen-
tially as described by Chirgwin et al. (1979). Briefly, up to
I g of frozen tissue was ground to powder under liquid N2
and then homogenized in 10ml of guanidine isothiocyanate
buffer (50mM Tris/HCl pH 7.6, containing 10mM EDTA, 2%
(w/v) sodium lauryl sarcosine, 0.01% (v/v) ,B mercapto-
ethanol, and 4M guanidine isothiocyanate). Debris was
cleared from the homogenate by centrifugation at 10,000g
for 10min at 10°C, and the supernatant overlayed onto a
3ml CsCl cushion (5.7M CsCl, 100mM EDTA pH 8.0). This
was centrifuged in a Beckman SW40 rotor at 30,000 rpm for
18h at 20°C. Following centrifugation, the supernatant was
discarded and the RNA pellet rinsed with 70% (v/v) ethanol
and resuspended in 1 ml of guanidine HCI buffer (7 M
guanidine HCI, 10mM sodium iodoacetate, 20mm sodium
acetate, 1 mM dithiothreitol, 20mM EDTA pH 7.0). RNA
was precipitated directly from this buffer by addition of half
a volume of absolute ethanol, at -20°C overnight. RNA
was recovered by centrifugation, and reprecipitated twice
before being resuspended in 10mM Tris HCI pH 8.0, 1mM
EDTA and stored at -70°C.
The poly(A)-containing RNA was isolated from total
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cellular RNA by affinity chromatography on oligo-dT cellu-
lose, essentially as described by Craig et al. (1976), except
that column equilibration and binding was performed in
10mM HEPES pH 7.5 containing 500mm lithium chloride,
and 0.2% (w/v) SDS, while elution was with 10mM HEPES
pH 7.5 containing 0.2% (w/v) SDS at 60°C.
Construction and screening of mammary carcinoma cDNA
libraries in AgtJO
Representative cDNA libraries were prepared from total
poly(A)-containing RNA isolated from breast carcinoma
tissue. Double stranded cDNA was synthesised from 2 pg
poly(A)-containing RNA, according to conditions described
by Riley et al. (1986). Subsequent modification of the
cDNA, ligation to EcoRI restricted AgtlO DNA and
packaging into Agt1O phage particles was as detailed by
Huynh et al. (1985).
Cross-screening of the cDNA libraries using 32P-labelled
cDNA was carried out at low density (1-2x 103pfu/9 cm
plate) using the hybridisation conditions described by Benton
& Davis (1977). Individual differentially expressed recom-
binant phage plaques were picked, amplified in liquid
culture, and cDNA inserts excised and subcloned directly
into the EcoRI site of pUC 13 using procedures described by
Maniatis et al. (1982). EcoRI excised inserts from this
subclone were then ligated into M13 vectors (MplO, Mpll)
for DNA sequence analysis (Sanger et al., 1977) and Si
mapping experiments. Inserts were also recloned into Gemini
vectors (pGEM 1, pGEM 2) for preparation of RNA
transcripts for in situ hybridisation.
RNA blotting and S1 mapping
Analysis of poly(A)-containing RNA by RNA blotting was
carried out as described by Taylor et al. (1984). Probes were
labelled with [a32P]dCVP by nick translation (Rigby et al.,
1977).
S, mapping experiments were performed employing con-
ditions modified from Berk & Sharp (1977), using a single
stranded 32P-labelled M13 DNA probe, prepared essentially
as described by Myers et al. (1985). Hybridisation reactions
were incuba$ed at 52°C for 18h, and Si nuclease digestion
was at 37°C for 1 h. Protected fragments were analysed by
electrophoresis on 6% (w/v) polyacrylamide urea gels.
In situ hybridisation
Tumour blocks were sectioned (5yu) on a microtome and
sections layered onto clean, sterile, poly-L-lysine coated glass
slides (Huang et al., 1983). These were baked at 37°C
overnight prior to storage at room temperature in a dry,
dust-free box. Sections stored in this manner have been
successfully used over a period of 6 months. Prior to use
sections were dewaxed by sequential immersion of slides in
xylene, followed by stepwise rehydration through alcohol.
Further pre-treatment of sections prior to in situ
hybridisation, was performed as detailed by Hoefler et al.
(1986).
Radiolabelled sense and anti-sense RNA probes were
synthesised from HindlIl linearised pGEM 1 (cRNA) and
pGEM 2 (mRNA) constructs, by incorporation of
[x-32P]CTP into transcripts from the T7 promoter, as
modified by Promega (technical bulletin) from Melton et al.
(1984). RNA probe (4ng), corresponding to 2 x 106 cpm, was
applied to each section in 20,pl hybridisation buffer.
Hybridisation was performed as described by Hoefler et al.
(1986). After washing and dehydration, the slides were
coated in Ilford liquid nuclear track emulsion (K5), dried
and exposed at 4°C in light-tight boxes for 2-10 days. Slides
were developed at 20°C in Kodak D19 developer, and fixed
in 5% (w/v) sodium thiosulphate. Sections were counter-
stained with haematoxylin and eosin prior to microscopic
examination.
Results
Identification Of K-mRNA in RNA preparations from
primary breast carcinoma
We have constructed a number of representative AgtIO
cDNA libraries (2-3 x 106 recombinants) from poly(A)-
containing RNA isolated from primary breast carcinomas
containing oestrogen and progesterone receptors or no
receptors, and from primary breast carcinomas which on the
criteria of size, grade, lymph node involvement, extracellular
HMFG staining, and receptor status, are indicative of good
or bad prognosis (see Table I). Direct cross-screening of
these libraries with 32P-labelled cDNA probes using
strategies to identify cloned mRNA species prevalent for
example in the tumour of potentially bad as opposed to
good prognosis, repeatedly resulted in the identification of
immunoglobulin K-light and y-heavy chain mRNA
sequences, data consistent with the view that there was
significant infiltration by B-cells of the 'poor' prognosis
tumour relative to that of 'good' prognosis (Collis, 1988).
In order to investigate the possibility that levels of
immunoglobulin mRNA expression might prove a useful
prognostic factor, we have used one of these cloned
sequences (phZH2) as a hybridisation probe to quantitate
and localise the site of immunoglobulin mRNA expression in
breast cancer. The cloned cDNA inserted in phZH2 (Figure
1) comprises a 256 bp fragment of K light chain mRNA,
containing an open reading frame, encoding part of the
variable region (Vk), J-region (Jk) and part of the constant
region (Ck). Comparison of the deduced amino acid sequence
with other available K-chain amino sequences in the Vk
regions demonstrated amino acid sequence homology with K
subgroup IV (see Klobeck et al., 1985; Marsh et al., 1985).
We have used this KiV cDNA sequence, recloned into
Table I Clinical parameters used to define tumours of potentially good and bad prognosis
Poora Gooda
Patient no. 13 19 44 76 78 60 92 127 130 132
Age 54 53 67 54 73 64 49 58 37 76
Menopausal status Pre Pre Post Pre Post Post Pre Post Pre Post
Tumour size (cm) 10 6 6 8 2 6 3 3 2 1.5
Node involvement + - + + - - - -
Pathologyb IDC IDC IDC IDC IDC IDC IDC IDC/ILC IDC IDC/ILC
Gradec III III III III III I I ND I ND
Receptors ER/PR -I- +/- +/+ -I- -I- +/+ +/+ +- -/+ +/+
Extracellular milk fat globule
antigen (ECS)d - - - + + + +
Rime to relapse (m) 12 10 7 1 7 - - 3
Time to death (m) 21 32 _ 14 14 -
aSelected on basis of tumour size, grade, nodal involvement, ECS with HMFG and disease free interval; bInfiltrating duct
carcinoma (IDC). Mixed infiltrating duct/infiltrating lobular carcinoma IDC/ILC; cRichardson & Bloom (1957); dWilkinson
et al. (1984). We took ECS to be a good prognostic feature.PLASMA CELLS AND POOR PROGNOSIS IN BREAST CANCER 717
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THR LEU THR ILE SEP SER LEU GLN ALA GLU ASP ALA ALA VAL TYR TYR CYS GLN GLN TYR
ACT CTC ACC ATC AGC AGC CTG CAG GCT GAA GAT GCG GCA GTT TAT TAC TGT CAG CAA TAT 60
JR
VAL SER THR PRO ARG ALA PHE GLY PRO GLY THR LYS VAL GLU ILE LYS ARG THR VAL ALA
GTG AGT ACT CCT CGT GCA TTC GGC CCA GGG ACC AAG GTG GAA ATC AAA CGA ACT GTG GCT 120
ALA PRO SER VAL PHE ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SER
GCA CCA TCT GTC TTC ATC TTC CCG CCA TCT GAT GAG CAG TTG AAA TCT GGA ACT GCC TCT 180
C'
VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU ALA LYS VAL GLN TAP LYS VAL ASP
GTT GTG TGC CTG CTG AAT AAC TTC TAT CCC AGA GAG GCC AAA GTA CAG TGG AAG GTG GAT 240
ASN ALA LEU GLN SER
AAC GCC CTC CAA TCG 3, 255
Figure 1 Nucleotide sequence of immunoglobulin KIV light chain
mRNA cloned in phZH2. Nucleotide sequence analysis was
performed on both stands and across all restriction sites used in
the sequencing strategy as described in Materials and methods.
Deduced amino acid sequence encoding variable region (VK),
J-region (Vj), and constant region (CK) is indicated.
appropriate vectors, to investigate by RNA blotting, S1
mapping and in situ hybridisation the relative levels, and site
of synthesis of K-chain mRNA in RNA isolated from
primary breast carcinomas, which, on a number of criteria
(see Table I) were predicted to be of 'good' or 'bad'
prognosis. This selection was found later to be reasonably
accurate since on follow up all the tumours with features of
a poor prognosis have resulted in relapse in all patients and
death in 4 out of 5 within 32 months, whereas those with
features of a good prognosis are alive 30-40 months after
mastectomy, of which only one has relapsed (see Table I).
Initially the levels of K-chain mRNA expressed in tumour
RNA were assessed by RNA (Northern) blotting relative to
actin mRNA in a small group of tumours. Total poly(A)-
containing RNA was separated on the basis of size by gel
electrophoresis, blotted onto Biodyne membranes and co-
probed with 32P-labelled phZH2 and pAM-91 (actin) cDNA
probes. A typical result (Figure 2), demonstrates the
presence of an intense band of the expected size of K-chain
mRNA (11OOntds) in three RNA preparations all from
tumours of bad prognosis, the presence of the same band in
the control tonsil RNA preparation, and the presence of low
levels only of K-chain mRNA in the two good prognosis
tumours examined in this instance. The actin mRNA
(1600ntds) was present at approximately equivalent levels in
all RNA preparations.
In order to increase the sensitivity of our analyses,
conserve RNA, and to determine the relative level of
expression of K,1 mRNA to total K-mRNA, we have
performed Si mapping using a 327 ntd uniformly 32p_
radiolabelled M13 derived cDNA probe containing M13
i ii iii iv v vi
-Actin mRNA
-K-chain mRNA
1631 0
517-
396
0
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Figure 2 Identification of immunoglobulin K-chain mRNA in
RNA isolated from primary human breast carcinoma by RNA
blotting. Total poly (A) containing RNA (1 pg per track) isolated
from (i) human tonsil (T), and (ii-vi) five human primary breast
carcinoma of good (PB60, PB92) and bad (PB44, PB19, PB78 -
see Table I) prognosis, was analysed by RNA blotting for the
presence of immunoglobulin K-light chain mRNA and actin
mRNA (see text and Materials and methods). The position of
DNA size markers of 1631, 517, 396bp, and K-light chain and
actin mRNA is indicated.
polylinker sequence, and sequence encoding VkIV, Jk and Ck
(see Figure 3AI). The results (Figure 3BI) compare K-mRNA
levels in poly(A)-containing RNA isolated from five bad
prognosis, and five good prognosis tumours (see Table I)
with RNA from a tonsil (positive control), benign breast and
normal breast. In the tonsil control track, a number of
diffuse protected bands are apparent, the two most
prominent being of 183 and 175ntds, representing complete
protection of the Ck and Jk region of the probe, and limited
S, nuclease digestion of part of the 5' end of the Jk region
respectively. This was expected taking into account J region
duplication (Hieter et al., 1982) and junctional variation
during V-J recombination (Weigert et al., 1980). Some larger
but minor species were also present. These represent K,1
mRNA (256ntds) and protection of limited sequence in the
Vk region in addition to Jk and Ck sequence (194ntds).
Comparative analysis of all breast RNA preparations,
demonstrated that relative K-mRNA levels in the five 'bad'
prognosis tumours were 5-30-fold higher than K-mRNA
levels in the normal breast RNA preparations. In a com-
parison of the 'good' prognosis tumours, three showed
barely detectable levels of K-mRNA, and two had K-mRNA
levels 2-4-fold higher than normal breast RNA. KiV mRNA
was identified at low levels, in tonsil and two 'bad prognosis
tumours (PB13, PB44). The absence of detectable Kiv mRNA
in the remaining RNA preparations probably reflects the low
levels of total K-mRNA of which KlV mRNA is a minor
component.
In addition to our analysis of the relative levels of K-
mRNA, a potential marker for plasma cells in the tumour
tissues, we have also examined by Si mapping in the same
RNA preparations (see Figure 3AII), the relative levels of T-
cell receptor f-chain mRNA (Collins et al., 1985), an
equivalent marker for T cells. The results (Figure 3B11),
using the same RNA samples used for K-mRNA analysis,
show the expected protected T cell receptor mRNA band of
479ntds in the tonsil RNA preparation, identifying the
presence of T cell receptor mRNA. The protected band was
barely discernible in the benign and normal breast RNA
preparations, and of the remainder, only in one 'good'
prognosis RNA preparation were T cell receptor mRNA
levels significantly increased (2-3-fold) compared with
normal breast. Analysis of T cell receptor mRNA levels in
RNA preparations from bad prognosis tumours, showed a
small 2-3-fold increase, and in one instance a 10-15-fold
increase in T cell receptor mRNA levels relative to normal
breast. Overall T cell receptor mRNA levels were elevated in
tumour tissue, but there was no particular bias between good
and bad prognosis tumour RNA preparations.
Retrospective analysis of K-mRNA expression by in situ
hybridisation
The results described above on a relatively small number of
clinically well defined breast tumour preparations, provide
evidence for increased infiltration of primary breast tumours,
where the prognosis is poor, by cells of the immune system,
in particular B cells. The approach whilst revealing, is time
consuming, too complex for the routine pathology
laboratory, and inappropriate for retrospective studies where
available material is limited to formalin fixed paraffin
embedded blocks. We have therefore employed in situ
hybridisation using 32P-labelled K-chain cRNA hybridisation
probes to identify K-mRNA producing cells in paraffin
embedded formalin fixed tissue sections. Initially the validity
of the technique was established using tonsil, rapidly
processed post-operatively. As can be seen the morphology
of the section is retained in spite of prolonged hybridisations
(Figure 4a), and the K-chain cRNA probe hybridises strongly
to discrete regions of the tonsil tissue (as judged by auto-
radiography) consistent with the presence of a cuff of mature
plasma cells around reactive follicles. In contrast the 32P_
labelled K-chain mRNA probe showed no hybridisation toII
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Figure 3 S1 analysis of the relative amounts of immunoglobulin K--light chain mRNA and T cell receptor mRNA in RNA isolated
from human primary breast carcinoma. (A) Single stranded 32P-labelled cDNA probes specific for immunoglobulin K-chain mRNA
species (I) and TiC,B chain mRNA of the T cell receptor (II) were generated by recloning phZH2 cDNA (256bp) and 479bp
EcoRI fragment of PB400 into M13 (see Collins et al., 1985, and Materials and methods), resulting in cDNA hybridisation probes
of 327 and 550ntds respectively. (B) Si nuclease analysis of poly (A) containing RNA (SOOng per track) using (I) a KIV cDNA
probe, or (II) a T cell receptor fl-chain cDNA probe was carried out as described in Materials and methods. Samples were analysed
in the following order; track (i) tonsil RNA, tracks (ii-vi) poor prognosis tumour RNA (PB76, 13, 78, 19, and 44 respectively),
tracks (vii-xi) good prognosis tumour RNA (PB 132, 130, 127, 92 and 60 respectively) track (xii) benign breast carcinoma RNA,
and track (xiii) normal breast RNA. The relative mobility of Hinf I restricted pAT153 size markers of 298, 220 and 154pb, and
the size of bands resistant to S, nuclear digestion are shown.
tonsil tissue, thereby demonstrating the specificity of the
hybridisation probe (Figure 4b). Application of the same
approach to formalin fixed paraffin embedded sections
representative of good (PB60) and bad (PB78) prognosis
primary breast tissues, in this instance using sections cut
from blocks prepared without special precautions in a
routine hospital pathology environment, showed results
consistent with data obtained by RNA blotting and S,
mapping of RNA isolated from the same tissues (see Figures
2 and 3). Hybridisation of the 32P-labelled K-chain cRNA
probe to the bad prognosis tissue was intense and localised
to single cells scattered throughout the section, but focussed
in the stroma immediately surrounding although generally
not invading the tumour foci (Figure 4c). No hybridisation
was observed to any cells on examination of sections of good
prognosis tissue (PB60) which were processed in parallel to
the bad prognosis (PB78) using the same cRNA probe
preparations, hybridisation and autoradiographic solutions
(Figure 4d). In all experiments the control 32P-labelled K-
mRNA hybridisation probe showed no hybridisation to any
section when analysed in parallel and developed after an
identical period of exposure. In some instances regions of
'yellowing' were seen over single cells. Examination under
dark field microscopy showed no evidence for silver grains in
these regions, which we presume therefore may reflect an
artefact of the methodology. On the basis of the data
presented it would appear that in situ hybridisation can be
successfully applied to formalin fixed paraffin embedded
tissue sections, producing results in agreement with parallel
analysis of K-chain RNA expression by RNA blotting and Si
mapping in RNA isolated from snap frozen tissue from the
same tumours.
Having validated the technology and established the
potential prognostic value of the presence of plasma cells in
tumour tissue using a limited number of primary tumours
obtained from a relatively recent study, we have extended
our analysis to examine by in situ hybridisation the presence
of c-mRNA producing cells in paraffin sections taken from
34 formalin fixed primary breast carcinomas removed in
1976 at the Norfolk and Norwich Hospital. The tumours
were selected on the criteria that approximately half (n = 19)
were from patients who had succumbed to the disease during
a 10 year post-operative period, and the remainder were
from patients who were alive, and in some instances had no
recurrent disease, during the same period (n = 15) - see
Table IIA, B. Sections were cut from all the blocks, and the
number of K-mRNA producing cells in each grouping
examined by in situ hybridisation. Sections were scanned
under light microscopy, and the area of tissue within a
2.6mm2 field of view containing the greatest number of K-
mRNA producing cells scored blind. After a 48h exposure
period, out of the 15 blocks examined from the surviving
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Figure 4- Identification of cells expressing immunoglobulin K-
chain mRNA by in situ hybridisation. Immunoglobulin K-chain
cDNA cloned in phZH2 (256bp) was subcloned into pGEMl
and pGEM2, and used to generate 32P-labelled cRNA and
mRNA hybridisation probes as described in Materials and
methods. These were then used for in situ hybridisation to (a)
human tonsil (cRNA), (b) human tonsil (mRNA), (c) poor
prognosis primary breast carcinoma - PB78 (cRNA), and (d)
PB60 - good prognosis primary breast carcinoma (cRNA).
Sections were exposed for 48h.
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Figure 5 Comparison of the maximum number of immuno-
globulin K-chain producing cells present in a 2.6mm2 field of
view as judged by in situ hybridisation (see Figure 4, and text) in
sections from 11 year old formalin-fixed paraffin embedded
primary breast carcinoma tissue from patients now deceased or
still surviving (see Tables IIA, B). Exposure time was 48 h.
patients, hybridisation was undetectable in 14 sections and in
only one instance was hybridisation apparent, in this
instance to numerous single cells (Figure 5). In contrast, of
the 19 blocks examined from patients now deceased, three
showed no detectable K-mRNA producing cells, whilst the
remainder had positive cell counts ranging from 12 to 800
cells within the optimum field of view (Figure 5). Prolonged
exposure (5-7 days) identified a second population of cells to
which the probe hybridised weakly. Cell counts of this
population showed no significant bias towards either the
'good' or 'bad' prognosis groupings.
The in situ experiments described above have also been
performed using a A light chain constant region cRNA
probe. These results confirmed our observations using the K-
chain cRNA probe, but in addition, provided evidence that
the ratio of plasma cells producing K as opposed to A light
chain mRNA was unexpectedly high (4.5:1), when compared
with the expected ratio (2:1) which we have found in normal
tissue by in situ hybridisation.
Discussion
We have demonstrated using complementary but indepen-
dent approaches that the presence of elevated levels of
immunoglobulin K-chain mRNA in breast tumour tissue is
associated with poor prognosis. In particular, that cells
enriched in K-chain mRNA infiltrate tumours of 'poor' as
opposed to 'good' prognosis.
Lymphoplasmacytic infiltration within tumours has been
studied extensively and, according to the early literature, was
generally thought to be a favourable prognostic sign. A
review of earlier work (Underwood, 1974) reported that in 8
studies, five showed a correlation between cell infiltration
and 'good' prognosis, whereas three were negative. Since
that time there have been numerojis additional conflicting
rerports of associations between infiltration and for example
favourable prognosis (Black et al., 1975; Dawson et al.,
1982; Stenkvist et al., 1982), and poor prognosis (Roses et
al., 1982; Fisher et al., 1983). However, a consistent theme in
more recent studies has been the association of lympho-
plasmacytic infiltration and histological features of poor
prognosis such as poor grade, nuclear pleomorphism,
tumour necrosis and lymph node invasion by tumour (Black
et al., 1975; Lauder et al., 1977; Fisher et al., 1983; An et al.,
1987; von Kleist et al., 1987; Zuk & Walker, 1987).
Studies on lymphocyte subpopulations infiltrating breast
carcinoma and benign lesion by immunocytochemistry using
panels of monoclonal antibodies specific for various T cell
subtypes and B cells, uniformly agree that T cells
predominate, and that T cells were more abundant in
malignant as opposed to benign tissue (see Schoorl et al.,
1976; Hsu et al., 1981; Hurlimann & Soraga, 1985; Lwin et
al., 1985; An et al., 1987; von Kleist et al., 1987; Zuk &
Walker, 1987). B cells have variably been reported to be
absent or few in number in carcinoma, though Hurlimann
and Saraga (1985) report that B cells can represent up to
48% of the total number of T cells, whilst Zuk and Walker
(1987) provide evidence that the proportion of B cells
increase relative to T cells in carcinoma as opposed to
benign breast, with an overall B:T cell ratio as high as 1:2.
In all studies the prognostic significance of T cell sub-
population and B cell distribution was unclear.
Our study on ten primary breast tumours representative of
'good' and 'bad' prognosis (see Table I), in agreement with
previous studies, identified the presence of increased T cell
infiltration in the tumour population relative to normal
breast, as judged by the measurement of T cell receptor
mRNA. Furthermore, no significant trend of increased T cell
receptor mRNA in RNA from the 'bad' as opposed to
'good' prognosis tumour population was shown, and our
data provided no comparative data on B or T cell numbers.
However, levels of immunoglobulin K-chain mRNA (a
:
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Table II Clinical parameters of surviving and deceased 'Norwich' patients, who presented with breast carcinoma in 1976
Age at Menopausal Tumour
Patient no. presentation status size (cm)
162902
391162
450368
484672
490319
470718
253608
146001
486849
230532
093831
013029
489891
013986
405980
37
47
31
55
78
47
44
66
43
66
53
55
64
63
43
Pre
Peri
Pre
Peri
Post
Peri
Pre
Post
Pre
Post
Peri
Peri
Post
Post
Peri
1.0
2.0
4.0
1 -2b
1.5
3.0
-2b
2-5b
1-2b
1 -2b
1.5
1.5
2.0
2.0
2-5b
(A) Survivors
Nodea Time to
Pathology Grade involvement relapse (m)
IDC
ILC
IDC
IDC
IDC
Medullary CA.
Medullary CA.
IDC
IDC
ILC
IDC
ILC
ILC
IDC
IDC
I
I
II
I
I
II
III
II
II II
II
II
II
II
11
120
9
134
120
Age at Menopausal Tumour
Patient no. presentation status size (cm)
152202
459639
135646
175169
487326
373311
344370
199775
348408
340155
463179
484818
427389
484848
517453
343639
467777
057362
048695
62
64
56
66
55
58
60
66
51
48
65
67
43
60
58
61
52
59
47
Post
Post
Post
Post
Post
Post
Post
Post
Peri
Peri
Post
Post
Pre
Post
Post
Post
Peri
Post
Pre
1.5
2.0
4.0
2.0
1.0
2.5
2.0
1.5
2.0
3.0
2.5
1-2b
2-5b
3.0
2.5b
1-2b
1 -2b
2-5b
1.3
(B) Deceased
Nodea Time to
Pathology Grade involvement relapse (m)
IDC
IDC
IDC
IDC
ILC
IDC
IDC
IDC
IDC+ILC
(mixed)
IDC
IDC
IDC +
Paget's
IDC
IDC
IDC
IDC
IDC
IDC
IDC
III
III
II
III
II
II
III
II
III IDC/
II ILC
III
I
II
III
II
II
II
II
III
24
16
2
26
26
27
53
40
60
21
27
8
32
41
19
13
Time to In situ
death (m) cell count
6
35
23
21
36
68
57
107
110
66
40
38
20
11
70
21
46
31
49
55
12
36
240
0
32
46
80
24
85
112
0
29
161
0
29
85
800
35
"Determined by pathological examination; bTumour size estimated or measured from histology section.
marker for 70% of resting B cells or plasma cells) were
significantly elevated in RNA isolated from tumours of 'bad'
as opposed to 'good' prognosis, relative to normal breast. In
situ hybridisation using a 32P-labelled K-chain cRNA
hybridisation probe supported data obtained on tumours
PB78 (bad) and PB60 (good) obtained using Si mapping and
RNA blotting. Moreover, in situ hybridisation demonstrated
that the cells expressing K-chain mRNA were not of tumour
origin, were scattered throughout the stroma sometimes
surrounding but not invading tumour foci, and were
morphologically identical to cells of lymphoplasmacytic
origin variously described in the literature. Since the K-
mRNA is very abundant in these cells, as determined by the
relatively short exposure time, we would presume that we
have identified plasma cells, as opposed to resting B cells.
The latter would also express K-chain mRNA, but at a very
much reduced level (50-100-fold - see Kelly & Perry, 1986).
In this respect the tonsil tissue controls are of importance.
These not only define the specificity of the cRNA
hybridisation probe, but also demonstrate that under the
conditions of hybridisation used, plasma cells as opposed to
resting B cells have been localised. The identification of an
additional population of cells after prolonged exposure, may
reflect the localisation of resting B cells in addition to the
plasma cells.
Analysis of the distribution of plasma cells in archival,
paraffin embedded formalin-fixed tissue, using blocks
prepared without special precautions from tumours removed
from patients operated upon over ten years earlier, provided
data which confirmed and extended the data generated via a
detailed molecular analysis of K-chain mRNA levels and
localisation in the ten selected tumours of potentially 'good'
and 'bad' prognosis. In this study, plasma cells were found
in tumours from 84% of women who had relapsed and died,
whereas only in one of the tumours (6%) from women who
survived 10 years or more were plasma cells detected. It is of
interest that the single tumour in the group of survivors in
which plasma cell infiltration was considerable, was a
medullary carcinoma, a tumour type associated with 'good'
prognosis (Ridolfi et al., 1977) with characteristic lympho-
plasmacytic infiltration (Hsu et al., 1981).
Clinically our studies would suggest that the presence of
plasma cells in infiltrating duct carcinoma and mixed infil-
trating duct and lobular carcinoma is associated with a poor
prognosis. It would also appear, in agreement with previous
studies (Ridolfi et al., 1979; Hsu et al., 1981) that plasma
cells are present in medullary carcinoma of the breast, and
that in these tumours the presence of plasma cells does not
reflect a 'poor' prognosis.
Technically our studies emphasise the potential value of in
situ hybridisation in routine pathology, and demonstrate that
data may be generated after a period of 10 years from tissue
fixed and embedded without special precautions to eliminate
nuclease degradation of mRNA. The technology described in
this paper relies on short-half life 32P-labelled cRNA as the
hybridisation probe. However, since the K-chain mRNA is
In situ
cell count
0
0
0
0
0
500
0
0
0
0
0
0
0
0
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highly abundant in plasma cells and therefore well within the
detection limits of non-radiolabelled biotin-streptavidin and
similar detection systems, the development of non-
radiolabelled K-chain cRNA hybridisation probes suitable for
bulk synthesis and therefore routine use would not appear to
be an insuperable objective. The use of defined hybridisation
probes also should eliminate much conflicting evidence
obtained from similar clinical studies obtained using antisera
of differing specificity, and in addition, overcome problems
associated with the use of monoclonal antibodies on formalin
fixed paraffin sections.
A larger more detailed study to determine whether plasma
cell infiltration is a true independent prognostic factor or
whether it is related to other histological features of
prognosis in mammary tumours would now be of value.
Such a study should include for comparison a parallel
analysis of B and T cell markers using a panel of
monoclonal antibodies.
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